Novel technetium-99m-labeled platelet GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosis

Coronary Artery Disease

Volumn 9, Issue 2-3, 1998, Pages 131-141

  Mousa, Shaker A ^a   Bozarth, Jeff M ^a   Edwards, Scott ^b   Carroll, Timothy ^b   Barrett, John ^b  

^a DUPONT COMPANY   (United States)

^b Radiopharmaceutical Division   (United States)

Author keywords

Diagnosis of venous and arterial thrombosis; Integrins; Platelet GPIIb IIIa receptors; Thrombin inhibitors; Thrombus imaging

Indexed keywords

CYCLO(DEXTRO 2 AMINOBUTYRYL 2 N METHYLARGINYLGLYCYLASPARTYL 3 AMINOMETHYLBENZOIC ACID) METHANESULFONATE; FIBRINOGEN RECEPTOR ANTAGONIST; RECEPTOR; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOVENOUS SHUNT; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOT; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; DIAGNOSTIC VALUE; DISEASE COURSE; DOG; LUNG EMBOLISM; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBUS; VEIN THROMBOSIS;

EID: 0031808479     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199802000-00011     Document Type: Article

References (25)

1. Ashby B, Daniel JL, Smith JB. Mechanisms of platelet activation and inhibition. Platelet in Health & Disease 1990; 4:1-26.
2. Davies MJ, Thomas AC. Plaque fissuring - the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985; 53:363-373.
3. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315:983-989.
4. Fuster V, Steele PM, Chesebro JH. Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. J Am Coll Cardiol 1985; 5:175B-184B.
5. D'Souza SE, Ginsberg MH, Burke TA, Plow EF. The ligand binding site of the platelet integrin receptor GPIIb/IIIa is proximal to the second calcium binding domain of its a subunit. J Biol Chem 1990; 265:3440-3446.
6. Philips DR, Charo IF, Scarborough RM. GPIIb/IIIa: the responsive integrin. Cell 1991, 65:359-362.
7. Pytela R, Pierschbacher MS, Ginsberg MH, Plow EF, Ruoslahti E. Platelet membrane glycoprotein IIb/IIIa: members of a family of RGD specific adhesion receptors. Science 1986; 231:1559-1562.
8. Mousa S, Bennett JS. Platelet in health and disease: platelet GPIIb/IIIa structure and function: recent advances in antiplatelet therapy. Drugs of the Future 1996; 21:1141-1154.
9. Mousa S, Bozarth J, Forsythe M, Lorelli W, Jackson S, Ramachandran N, et al. Antiplatelet efficacy and specificity of a novel platelet GPIIb/IIIa receptor antagonist, DMP728. Cardiology 1993; 83:374-382.
10. Mousa S, Bozarth J, Forsythe M, Jackson S, Leamy A, Diemer M, et al. Antiplatelet, antithrombotic efficacy of DMP728, a novel platelet GPIIb/IIIa receptor antagonist. Circulation 1994; 89:3-12.
11. Nichols AJ, Ruffolo RR, Huffman WF, Poste G, Samanen J. Development of GPIIb/IIIa antagonists as antithrombotic drugs. Trends Pharmacol Sci 1992; 13:413-417.
12. Coller BS, Folts JD, Scudder LE, Smith SR. Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model. Blood 1986; 68:783-786.
13. Topol EJ. Novel antithrombotic approaches to coronary artery disease Am J Cardiol 1995; 75:27b-33b.
14. Knight L. Radiopharmaceuticals for thrombus detection. Semin Nucl Med 1990; 20:52-67.
15. Anderson FA, Wheeler HB, Goldberg RT, Homer DW, Patwardhan NA, Jovanovic B, et al. A population-based perspective of the hospital incidence and cause facility rates of deep vein thrombosis and pulmonary embolism. Ann Intern Med 1991; 151:933-938.
16. Hull RD, Hirsh J, Carter CJ, Jay RM, Dodd PE, Ockelford PA, et al. Pulmonary angiography, ventilation lung scanning and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med 1983; 98:891-899.
17. Mosner K. Venous thromboembolism. Am Rev Respir Dis 1990; 141:235-249.
18. Bennett JS, Vilaire GO. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979; 64:1393-1401.
19. O'Neil K, De Grado W, Mousa S, Ramachandran N, Hoess R. Identification of recognition sequences of adhesion molecules using phage display technology. Methods Enzymol 1994; 245:370-386.
20. Schafer AI. Antiplatelet therapy. Am J Med 1996; 101:199-209.
21. Tsao PW, Bozarth JM, Jackson S, Forsythe M, Flint S, Mousa SA. Platelet GPIIb/IIa receptor occupancy studies using a novel fluoresceinated cyclic Arg-Gly-Asp peptide. Thromb Res 1996; 77:543-556.
22. Oster Z, Srivastava S, Som P, Meinken G, Scudder L, Yamamoto L, et al. Monoclonal antiplatelet antibody. Proc Natl Acad Sci USA 1985; 82:3465-3468.
23. Knight L, Mauer A, Romano J, Buczala S. Preliminary evaluation of labeled disintegrins for thrombus imaging [abstract]. J Nucl Med 1993; 34:66.
24. Knight L, Lister-James J, Dean R, Mauer A. Evaluation of Tc-99m labeled cyclic peptides for thrombus imaging [abstract]. J Nucl Med 1993; 34:17.
25. Davidson B, Elliott CG, Lensing AWA. Low accuracy of color Doppler ultrasound in the detection of proximal leg vein thrombosis in asymptomatic high risk patients. Ann Intern Med 1992; 17:202-203.